Which outcomes should be used in future bronchiolitis trials? Developing a bronchiolitis core outcome set using a systematic review, Delphi survey and a consensus workshop

• Matthew Peak,
• Ricardo M Fernandes,
• Kerry Woolfall,
• David Lacy,
• Emma Bedson,
• Mark David Lyttle,
• Paula R Williamson,
• Paul S McNamara,
• Ashley P Jones,
• Vanessa Compton,
• Clare van Miert,
• Kentigern Thorburn,
• A Rosala-Hallas

Affiliations

Matthew Peak

Paediatric Medicines Research Unit, Alder Hey Children`s NHS Foundation Trust, Liverpool, UK

Ricardo M Fernandes

3 Instituto de Medicina Molecular, Clinical Pharmacology and Therapeutics, Faculty of Medicine, Universidade de Lisboa, Lisbon, Portugal

Kerry Woolfall

Institute of Population Health, Department of Public Health, Policy and Systems, University of Liverpool, Liverpool, UK

David Lacy

5 Department of Paediatrics, Wirral University Teaching Hospital NHS Foundation Trust, Wirral, UK

Emma Bedson

1 Liverpool Clinical Trials Centre, Department of Biostatistics, University of Liverpool (a member of Liverpool Health Partners), Liverpool, UK

Mark David Lyttle

Emergency Department, Bristol Royal Hospital for Children, Bristol, UK

Paula R Williamson

director, professor

Paul S McNamara

11 Institute of Child Health, University of Liverpool, Liverpool, Merseyside, UK

Ashley P Jones

Liverpool Clinical Trial Centre, University of Liverpool, Liverpool, UK

Vanessa Compton

2 Paediatric Intensive Care Unit, Alder Hey Children’s NHS Foundation Trust, Liverpool, Merseyside, UK

Clare van Miert

2 Paediatric Intensive Care Unit, Alder Hey Children’s NHS Foundation Trust, Liverpool, Merseyside, UK

Kentigern Thorburn

Paediatric Intensive Care Unit, Alder Hey Children`s Hospital, Liverpool, UK

A Rosala-Hallas

Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, Merseyside, UK